Dandelions are not weeds! They are wild vegetables. In Greek mythology Wholesale New NFL Jerseys , Hecate fed Theseus dandelions for 30 days so he would become powerful enough to defeat the Minotaur. Though this is just the stuff of legend, this story gives us an insight as to the powerful properties of the lowly dandelions.
In fact, the U.S. Department of Agriculture has declared that dandelions are more nutritious than broccoli and spinach. Attractive to birds and deer, these wild vegetables make excellent food for gerbils, hogs, cows, horses, and poultry.
Do you know that in Pueblo, Colorado it is illegal to grow dandelions? These folks are certainly missing a lot. Dandelions may taste bitter, but if harvested and cooked right, they can be delicious while they are downright nutritious.
And here are some more little known facts. Dandelions have medicinal value as a diuretic; fats and cholesterol cutter; gas pain reliever; treatment for kidney stones; cancer and diabetes fighter; blood cleanser; weight reducer; vision sharpener; skin and acne treatment; bowel functions regulator; blood pressure controller; and, solution to the anemia problem.
Dandelions can flavor beverages and juices; and may be used in recipes for omelets, salads, gelatins, quiche, soup, pasta dishes, breads, pizza, gravy, dips, spreads, pies, cookies, jellies, waffles, fritters, and pudding. And did we mention ice cream?
All parts of the dandelion are useful. The leaves can be cooked as table vegetables; the blossoms transformed into wines and jelly; and last but not the least, the roots can be made into coffee. So the next time you pass by a field of dandelions, don't just remark out how yellow the whole place looks-pick some along the way, and try them for lunch!
Find out more about alternative remedies at Global Medical Survey On Potassium Voltage Gated Channel Subfamily KQT Member 2 Health Articles | August 16, 2016
"The Report Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - "
Description
聽
Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016
聽
Summary
聽
Global Markets Directs, Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016, provides in depth analysis on Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) targeted pipeline therapeutics.
聽
The report provides comprehensive information on the Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) targeted therapeutics development and features dormant and discontinued projects.
聽
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, companyuniversity websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from companyuniversity sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
聽
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
聽
View Report At:
聽
Scope
聽
- The report provides a snapshot of the global therapeutic landscape for Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2)
- The report reviews Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) targeted therapeutics under development by companies and universitiesresearch institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages